GENOME ANNOUNCEMENT
===================

Tuberculosis (TB) caused about 1.3 million deaths worldwide in 2012, and about 3.6% of newly diagnosed TB cases along with 20% of previously treated TB cases in the world were multidrug-resistant tuberculosis (MDR-TB) ([@B1]). By the end of 2012, 92 countries reported extensively drug-resistant TB (XDR-TB) cases to WHO and an estimated 9.6% of MDR-TB cases were XDR-TB ([@B1]). The continued spread of MDR/XDR-TB is a serious threat to all nations of the world with the potential of making health care infrastructures useless in developing countries, such as China. Results from national surveys of drug-resistant TB in China confirmed that China faces serious challenges in combating MDR/XDR-TB, and primary transmission accounts for most of the MDR/XDR-TB cases ([@B2], [@B3]). Previously, we reported that the prevalence of MDR/XDR-TB in Zunyi, Guizhou Province, was higher than China's national average prevalence ([@B4]).

Several XDR-TB genomes from different countries, including China, have been sequenced ([@B5][@B6][@B9]), but none of them is specifically from Zunyi, Guizhou Province. To better understand the genetic mechanism underlining the extensive drug-resistance of *M. tuberculosis* strains and to identify new mutations in known and new genes associated with XDR, it is necessary to sequence the whole-genomes of clinical isolates of XDR-TB. Here, we announce the draft whole-genome sequences of two XDR-TB strains, ZMC13-264 and ZMC13-88, isolated in 2013 from TB patients in Zunyi, Guizhou Province of China.

Whole-genome sequencing was performed by using an Ion Torrent sequencing platform (Life Technologies). The genomic DNA samples of ZMC13-264 and ZMC13-88 were sequenced to about 290× coverage. The process generated 3,234,924 and 3,435,034 total reads, 632,975,164 and 653,240,179 total bases, with mean read lengths of 195 bp and 190 bp for ZMC13-264 and ZMC13-88, respectively. The draft whole-genome sequences for ZMC13-264 and ZMC13-88 are composed of 4,411,507 bp and 4,411,515 bp, containing 2,210 and 2,071 variants, respectively. We obtained the numbers of variants by comparing the genomes to the *M. tuberculosis* H37Rv complete genome (GenBank accession no. NC_000962.3). The G+C contents for both genomes are almost the same (65.60%). The assembled sequences were annotated by using the Rapid Annotation of microbial genomes using Subsystems Technology (RAST) ([@B10]), which revealed 3,914 and 3,917 protein-coding genes, along with 50 and 48 RNA-coding genes for ZMC13-246 and ZMC13-88, respectively.

The announcement of whole-genome sequences of two XDR *M. tuberculosis* strains, ZMC13-264 and ZMC13-88, isolated from patients in Zunyi, Guizhou Province of China, will provide a foundation for comprehensive comparison with XDR-TB genomes from different countries and regions of the world ([@B5][@B6][@B9]), as well as the standard reference H37Rv genome ([@B11]). The comparative genomic analysis of these genome sequences will facilitate the identification of new mutations in known and/or new genes associated with XDR-TB and give us more insights into the genetic and epidemiology variations occurring in XDR-TB strains circulating in Zunyi, Guizhou Province of China.
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The whole-genome sequences of two XDR-TB strains from Zunyi, China, have been deposited in the GenBank database under accession numbers [CP009100](CP009100) and [CP009101](CP009101).

**Citation** Chen L, Zhang DT, Zhang J, Su YA, Zhang H. 2014. Whole-genome sequences of two clinical isolates of extensively drug-resistant *Mycobacterium tuberculosis* from Zunyi, China. Genome Announc. 2(5):e00910-14. doi:10.1128/genomeA.00910-14.

This work was supported by the National Natural Science Foundation of China (81160003), the Key Project of Chinese National Programs (2013ZX10003007-001-003), and the Second 2011 Collaborative Innovation Center of Guizhou Province for TB Prevention and Control in Guizhou Province (Incubation Project).
